Literature DB >> 26995794

Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls.

Jennifer W Tidey1, Rachel N Cassidy2, Mollie E Miller2.   

Abstract

INTRODUCTION: Reducing the nicotine content of cigarettes to a minimally addictive level has been proposed as a regulatory strategy for reducing tobacco dependence. However, smokers with schizophrenia (SS) may be prone to changing their smoking topography in efforts to compensate for the reduction in nicotine content. The aims of this study were to compare smoking topography characteristics of usual-brand and very low nicotine content (VLNC) cigarettes in SS and control smokers without psychiatric illness (CS), and to determine whether nicotine replacement reversed any changes in topography produced by VLNC cigarettes.
METHODS: Using a within-subjects, counter-balanced design, SS (n = 27) and CS (n = 23) smoked usual brand cigarettes, VLNC cigarettes while wearing placebo patches (VLNC + PLA), or VLNC cigarettes while wearing transdermal nicotine patches totaling 42mg (VLNC + NIC) during 5-hour ad libitum smoking sessions. Cigarettes were smoked through topography measurement devices.
RESULTS: Across conditions, SS smoked more puffs per session and per cigarette, had higher cigarette volumes, and had shorter inter-puff intervals than CS (Ps < .01). During VLNC cigarette sessions, puff duration increased and time between puffs decreased, but participants smoked fewer puffs, resulting in a net decrease in cigarette and total session volume (Ps < .001). There were no significant interactions between group and condition.
CONCLUSIONS: These findings indicate that acute use of VLNC cigarettes does not increase intensity of smoking in SS, and support the feasibility of a nicotine reduction policy. IMPLICATIONS: Reducing the nicotine in cigarettes to a minimally addictive level has been proposed as a means of reducing tobacco dependence. However, smokers, particularly those with schizophrenia (SS) may alter their puffing in an attempt to extract more nicotine from VLNC cigarettes. This study compared smoking topography of usual brand versus VLNC cigarettes, combined with placebo or transdermal nicotine patches, in SS and controls. Although some changes in topography were indicative of compensatory smoking, total puffs and total cigarette volume were reduced with VLNC cigarettes, indicating that acute VLNC cigarette use does not increase smoking in SS.
© The Author 2016. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26995794      PMCID: PMC4978982          DOI: 10.1093/ntr/ntw089

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  38 in total

Review 1.  Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents.

Authors:  L T Kozlowski; R J O'Connor
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

2.  Puffing topography as a determinant of smoke exposure.

Authors:  R B Bridges; J G Combs; J W Humble; J A Turbek; S R Rehm; N J Haley
Journal:  Pharmacol Biochem Behav       Date:  1990-09       Impact factor: 3.533

Review 3.  Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking.

Authors:  J E Rose; E D Levin
Journal:  Br J Addict       Date:  1991-05

4.  Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.

Authors:  Christopher G AhnAllen; L Cinnamon Bidwell; Jennifer W Tidey
Journal:  Nicotine Tob Res       Date:  2014-08-20       Impact factor: 4.244

5.  Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

Authors:  A Olincy; D A Young; R Freedman
Journal:  Biol Psychiatry       Date:  1997-07-01       Impact factor: 13.382

6.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

7.  Comorbidity of severe psychotic disorders with measures of substance use.

Authors:  Sarah M Hartz; Carlos N Pato; Helena Medeiros; Patricia Cavazos-Rehg; Janet L Sobell; James A Knowles; Laura J Bierut; Michele T Pato
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

Review 8.  A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.

Authors:  Victoria C Wing; Caroline E Wass; Debra W Soh; Tony P George
Journal:  Ann N Y Acad Sci       Date:  2011-11-30       Impact factor: 5.691

9.  Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia.

Authors:  Jill M Williams; Kunal K Gandhi; Shou-En Lu; Supriya Kumar; Marc L Steinberg; Brett Cottler; Neal L Benowitz
Journal:  Drug Alcohol Depend       Date:  2011-05-18       Impact factor: 4.492

10.  A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Authors:  Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George
Journal:  J Clin Psychiatry       Date:  2012-05       Impact factor: 4.384

View more
  21 in total

1.  Nicotine and addiction beliefs and perceptions among the US-born and foreign-born populations.

Authors:  Anh B Nguyen; Xiaoquan Zhao; Leah Hoffman; Aura Lee Morse; Janine Delahanty
Journal:  Prev Med       Date:  2018-06-26       Impact factor: 4.018

2.  Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.

Authors:  Stephen T Higgins; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Andrea C Villanti; John R Hughes; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Jeff S Priest; Joan M Skelly; Derek D Reed; Janice Y Bunn; Morgan A Tromblee; Christopher A Arger; Mollie E Miller
Journal:  Prev Med       Date:  2018-04-04       Impact factor: 4.018

3.  The Effect of Price on the Consumption of Reduced Nicotine Cigarettes.

Authors:  Steven A Branstetter; Russell Nye; Joseph J Sipko; Joshua E Muscat
Journal:  Nicotine Tob Res       Date:  2019-06-21       Impact factor: 4.244

4.  Reduced Nicotine Content Cigarettes and Cannabis Use in Vulnerable Populations.

Authors:  Maria A Parker; Joanna M Streck; Cecilia L Bergeria; Janice Y Bunn; Diann E Gaalema; Danielle R Davis; Anthony J Barrows; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Stephen T Higgins
Journal:  Tob Regul Sci       Date:  2018-09

5.  Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.

Authors:  Stephen T Higgins; Sarah H Heil; Stacey C Sigmon; Jennifer W Tidey; Diann E Gaalema; John R Hughes; Maxine L Stitzer; Hanna Durand; Janice Y Bunn; Jeff S Priest; Christopher A Arger; Mollie E Miller; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Derek D Reed; Joan M Skelly; Lauren Tursi
Journal:  JAMA Psychiatry       Date:  2017-10-01       Impact factor: 21.596

Review 6.  Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.

Authors:  Corinne Cather; Gladys N Pachas; Kristina M Cieslak; A Eden Evins
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 5.749

7.  Animal Research on Nicotine Reduction: Current Evidence and Research Gaps.

Authors:  Tracy T Smith; Laura E Rupprecht; Rachel L Denlinger-Apte; Jillian J Weeks; Rachel S Panas; Eric C Donny; Alan F Sved
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

Review 8.  A review of tobacco regulatory science research on vulnerable populations.

Authors:  Stephen T Higgins; Allison N Kurti; Marissa Palmer; Jennifer W Tidey; Antonio Cepeda-Benito; Maria R Cooper; Nicolle M Krebs; Lourdes Baezconde-Garbanati; Joy L Hart; Cassandra A Stanton
Journal:  Prev Med       Date:  2019-05-02       Impact factor: 4.018

Review 9.  Modeling nicotine regulation: A review of studies in smokers with mental health conditions.

Authors:  Jennifer W Tidey; Danielle R Davis; Mollie E Miller; Irene Pericot-Valverde; Rachel L Denlinger-Apte; Diann E Gaalema
Journal:  Prev Med       Date:  2018-07-03       Impact factor: 4.018

Review 10.  Reducing the relative value of cigarettes: Considerations for nicotine and non-nicotine factors.

Authors:  Cassidy M White; Dorothy K Hatsukami; Eric C Donny
Journal:  Neuropharmacology       Date:  2020-06-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.